262 related articles for article (PubMed ID: 9365847)
21. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
22. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
23. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT
Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
[TBL] [Abstract][Full Text] [Related]
24. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.
Benabdallah L; Rerolle JP; Peraldi MN; Noël LH; Bruneel MF; Carron PL; Morelon E; Kreis H
Am J Kidney Dis; 2002 Dec; 40(6):E20. PubMed ID: 12460065
[TBL] [Abstract][Full Text] [Related]
25. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR
Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
27. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
28. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?
Kim YS; Jeong HJ; Kim MS; Kim SI; Han DS; Park K
Clin Transplant; 1998 Apr; 12(2):104-8. PubMed ID: 9575397
[TBL] [Abstract][Full Text] [Related]
29. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
30. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
Nowacka-Cieciura E; Perkowska-Ptasińska A; Sulikowska-Rowińska A; Cieciura T; Wazna E; Durlik M
Transplant Proc; 2009; 41(1):441-5. PubMed ID: 19249576
[TBL] [Abstract][Full Text] [Related]
31. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy.
Jeong HJ; Kim YS; Kwon KH; Kim SI; Kim MS; Choi KH; Lee HY; Han DS; Park K
Pathol Int; 2004 Nov; 54(11):837-42. PubMed ID: 15533226
[TBL] [Abstract][Full Text] [Related]
32. [Steroid pulse therapy combined with tonsillectomy in a patient with IgA nephropathy complicated with tuberculous pleurisy].
Koike K; Tamaki K; Takeda K; Sugawara K; Wakasugi D; Okuda S
Nihon Jinzo Gakkai Shi; 2005; 47(5):552-6. PubMed ID: 16130412
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
34. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
[TBL] [Abstract][Full Text] [Related]
35. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
37. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
38. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
39. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
40. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
